REFERENCES
- Stewart FH, Harper CC, Ellertson CE, . Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA 2001;285:2232–9.
- Barot S. Making the case for a ‘contraceptive convenience’ agenda. Guttmacher Policy Rev 2008;11:11–6.
- Landau S, Besinque K, Chung F, . Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States. J Am Pharm Assoc 2009;49:43–50.
- Landau SC, Tapias MP, McGhee BT. Birth control within reach: A national survey on women's attitudes toward and interest in pharmacy access to hormonal contraception. Contraception 2006;74:463–70.
- Harper C, Balistreri E, Boggess J, . Provision of hormonal contraceptives without a mandatory pelvic examination: The first stop demonstration project. Fam Plann Perspect 2001;33:13–8.
- Sonnenberg FA, Burkman RT, Hagerty CG, . Costs and net health effects of contraceptive methods. Contraception 2004;69:447–59.
- Trussell J, Lalla AM, Doan QV, . Cost effectiveness of contraceptives in the United States. Contraception 2009;79:5–14.
- Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J, Nelson AL, eds. Contraceptive technology. New York: Ardent Media 2007.
- World Health Organisation. World Health Organisation effectiveness chart. Accessed 20 February 2012 from: http://whqlibdoc.who.int/publications/2011/9780978856373_eng_Chapter13-end.pdf., 2011
- Fiddes P, Scott A, Fletcher J, . Attitudes towards pelvic examination and chaperones: A questionnaire survey of patients and providers. Contraception 2003;67: 313–7.
- Larsen SB, Kragstrup J. Experiences of the first pelvic examination in a random sample of Danish teenagers. Acta Obstet Gynecol Scand 1995;74:137–41.
- Foster DG, Rostovtseva DP, Brindis CD, . Cost savings from the provision of specific methods of contraception in a publicly funded program. Am J Public Health 2009;99:446–51.
- Mavranezouli I. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: Analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline. Hum Reprod 2008;23:1338–45.